In Vivo Platelet Activation Following Myocardial Infarction and Acute Coronary Ischaemia

Summary

Forty-seven patients presenting with acute chest pain had in vivo platelet activity assessed by measuring plasma levels of the platelet-specific protein beta thromboglobulin (BTG), and by screening for the presence of circulating platelet aggregates. Nineteen patients with transmural myocardial infarction (MI), 21 patients with acute coronary ischaemia (CI), and 7 patients with non-cardiac chest pain (NCCP) were investigated in a serial study and compared with a normal control group. The means of all BTG determinations in the MI (34, ± SD = 21-57) and CI (33, ± SD = 19-57) groups were significantly higher than those in the NCCP group (24, ± SD = 17-34; p Ã0.01) and normal subjects (22,5, ± SD = 14-37; p Ã0.001). There was no difference in BTG between those with MI or CI, nor between the NCCP group and normal subjects. Raised numbers of circulating platelet aggregates could not be detected in either MI or CI. The mean BTG levels in both MI and CI patients were significantly raised, compared to normal subjects, on the first day of admission to hospital and remained so on each of the subsequent nine days. Neither heparin plus warfarin nor sulphinpyrazone had any significant effect in lowering BTG levels. 15/40 patients (37.5%) following MI and CI had repeatedly raised BTG levels throughout the study period, and it is suggested that these patients represent an “at risk” group that may benefit from anti-platelet therapy in secondary prevention studies.

Keywords

Platelets - Beta thromboglobulin - Myocardial infarction

• References

• 1 Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. The release of a human platelet specific protein measured by radioimmunoassay. Thromb Res 1975; 6: 543-548
• 2 Kaplan KL, Owen J. Plasma levels of beta thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 191-202
• 3 Harker LA. Platelets. In Recent Advances in Haematology 2. Hoffbrand AV, Brain MC, Hirsh J. (eds). Churchill Livingstone: 1977: 369
• 4 Harker LA, Ritchie JL. The role of platelets in acute vascular events. Circulation 1980; 62 (Suppl. 05) 13-18
• 5 Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G. Circulating platelet products in unstable angina pectoris. Circulation 1981; 63 (02) 300-306
• 6 Rasi V, Turstila I, Ikkala E. Beta thromboglobulin in acute myocardial infarction. Acta Med Scand 1980; 642 (Suppl. 00) 85-91
• 7 Celia G, Zahavi J, de Hass HA, Kakkar VV. Beta thromboglobulin, platelet production time, and platelet function in vascular disease. Br J Haematol 1979; 43: 127-136
• 8 Wu KK, Hoak JC. A new method for quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926
• 9 Andrassay K, Dopperman D, Ritz E, Koderisch J, Seeley H. Different effects of renal failure on beta thromboglobulin and high affinity platelet factor 4 concentrations. Thromb Res 1980; 18: 469-475
• 10 Ludlam CA, Cash JD. Studies on the liberation of beta thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-247
• 11 Ludlam CA. Evidence for the platelets specificity of beta thromboglobulin and studies on its plasma concentration in healthy individuals. Br J Haematol 1979; 41: 271-278
• 12 Prazich J, Rapaport SI, Samples JR, Engles R. Platelet aggregate ratios - standardisation of technique and test results in patients with myocardial ischaemia and patients with cerebrovascular disease. Thromb Haemostas 1977; 38: 597-605
• 13 Schwartz MB, Hawiger J, Timmons S, Friesinger GC. Platelet aggregates in ischaemic heart disease. Thromb Haemostas 1980; 43: 185-188
• 14 Haeren JW. Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. Atherosclerosis 1974; 19: 529-541
• 15 Anturane Reinfarction Trial Research Group. Sulphinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med 1980; 302: 250-256
• 16 Persantine-Aspirin Reinfarction Study Research Group. Persantine and Aspirin in coronary heart disease. Circulation 1980; 62: 449-461
• 17 The Aspirin Myocardial Infarction Study Research Group. A randomised controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661-669